MENU
+Compare
IMTX
Stock ticker: NASDAQ
AS OF
Apr 25, 04:59 PM (EDT)
Price
$4.52
Change
-$0.15 (-3.21%)
Capitalization
567.64M

IMTX Immatics NV Forecast, Technical & Fundamental Analysis

Immatics NV is a biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients... Show more

IMTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for IMTX with price predictions
Apr 24, 2025

IMTX in upward trend: price rose above 50-day moving average on April 23, 2025

IMTX moved above its 50-day moving average on April 23, 2025 date and that indicates a change from a downward trend to an upward trend. In of 52 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where IMTX's RSI Oscillator exited the oversold zone, of 32 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on April 17, 2025. You may want to consider a long position or call options on IMTX as a result. In of 86 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for IMTX just turned positive on April 14, 2025. Looking at past instances where IMTX's MACD turned positive, the stock continued to rise in of 49 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where IMTX advanced for three days, in of 281 cases, the price rose further within the following month. The odds of a continued upward trend are .

IMTX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 6 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where IMTX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.844) is normal, around the industry mean (14.237). P/E Ratio (28.505) is within average values for comparable stocks, (63.881). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.827). Dividend Yield (0.000) settles around the average of (0.024) among similar stocks. P/S Ratio (2.735) is also within normal values, averaging (255.011).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. IMTX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. IMTX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
IMTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

IMTX is expected to report earnings to fall 155.80% to -25 cents per share on May 20

Immatics NV IMTX Stock Earnings Reports
Q1'25
Est.
$-0.26
Q4'24
Beat
by $0.74
Q3'24
Beat
by $0.14
Q2'24
Beat
by $0.11
Q1'24
Beat
by $0.16
The last earnings report on March 27 showed earnings per share of 46 cents, beating the estimate of -28 cents. With 328.73K shares outstanding, the current market capitalization sits at 567.64M.
A.I. Advisor
published General Information

General Information

a clinical stage biopharmaceutical company, which engages in the research and development of T cell receptor-based immunotherapies for the treatment of cancer

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
Paul-Ehrlich-Strasse 15
Phone
+49 707153970
Employees
343
Web
https://www.immatics.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DIVPX15.610.06
+0.39%
MAI Managed Volatility Investor
RDEGX11.060.01
+0.09%
American Funds Dvlpg Wld Gr&Inc R2E
AEEIX14.57N/A
N/A
AB Global Real Estate Investment I
SOPAX29.28N/A
N/A
ClearBridge Dividend Strategy A
IMOZX23.86N/A
N/A
Voya MidCap Opportunities R6

IMTX and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, IMTX has been loosely correlated with RCKT. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if IMTX jumps, then RCKT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMTX
1D Price
Change %
IMTX100%
+3.55%
RCKT - IMTX
44%
Loosely correlated
+4.06%
ROIV - IMTX
42%
Loosely correlated
+2.42%
ACLX - IMTX
42%
Loosely correlated
+0.53%
DNTH - IMTX
42%
Loosely correlated
-1.53%
CGON - IMTX
42%
Loosely correlated
+3.81%
More